FEB 22, 2016 02:42 PM PST

New T-Cell Leukemia Treatment Target Identified

WRITTEN BY: Kara Marker
Around 15 to 20 percent of children with acute lymphoblastic leukemia (ALL) have cancerous cells derived from T lymphocytes (immune cells), as opposed to B lymphocytes (American Cancer Society). Currently, over half of adults and 20 percent of children with T-cell ALL end up dying. New research from Boston University Medical College (BUMC) researchers offers a potential solution for lowering those fatality rates; their new study published in Leukemia  identifies a specific enzyme that cancer cells rely on for survival.
 

 
During the tricarboxylic acid (TCA) cycle, a key step in the process of cellular aerobic respiration, cells transform pyruvate received from glycolysis into energy through oxidation of acetyl-CoA (Georgia State University). The new BUMC study identified a key enzyme involved in this process called DLST, which cancer cells require for adequate growth and survival. They discovered the cancer cell dependence on DLST by performing genetic screenings on a zebrafish model of disease, looking for specific mutations that suppress tumor development.
 
Indeed, inhibiting DLST in the zebra fish model “significantly delayed tumor onset in zebrafish without detectable effects on fish development” (Leukemia 2016). They also successfully tested DLST enzyme activity inhibition with human T-cell leukemia cells.
 
A new prospect for T-cell ALL treatment utilizing DLST inhibition is promising, especially because current treatments for this cancer are highly toxic even if they are successful in healing the patient. This finding is also significant because prior to this research, scientists did not believe that cancer cells relied on the TCA cycle for survival.
 
“Our new findings provide solid evidence that these cancer cells depend on the TCA cycle for their survival," explained corresponding author Hui Feng, MD, PhD. "Additionally we demonstrated the importance of DLST in T-cell leukemia development, and have identified a targetable enzyme for T-cell leukemia treatment.”
 

Source: BUMC
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 16, 2018
Immunology
MAY 16, 2018
Antibodies Neutralize Two Different Hemorrhagic Fever Viruses
Scientists have found evidence for potential antibody-based therapeutics to treat more than one hemorrhagic fever virus at once. From Harvard Medical Schoo...
JUN 15, 2018
Cardiology
JUN 15, 2018
Red Meat Allergy Causes Heart Disease
For people with an uncommon sensitivity to a particular carbohydrate in red meat, the risk of heart disease is elevated when consumed. From the National He...
JUN 20, 2018
Immunology
JUN 20, 2018
Immune System Accidentally Allows Meningitis Brain Infection
Several immune cells help fungi infect the brain and cause meningitis when they should be doing the exact opposite. From the University of Sydney, research...
AUG 18, 2018
Immunology
AUG 18, 2018
Two Proteins Play Unexpected Role in Immune System Regulators
Two proteins, PLD3 and PLD4, discovered to have role in immune system detection and response to pathogens....
AUG 24, 2018
Cell & Molecular Biology
AUG 24, 2018
Chronic Allergies can Change Cells
Chronic rhinosinusitis is different from allergies; it leads to serious inflammation and swelling in the sinuses that can last for years....
AUG 31, 2018
Immunology
AUG 31, 2018
B Cells Control Connective Tissue Disorder Scleroderma
Effector and Regulatory B cells play reciprocal role in pathogenesis of scleroderma....
Loading Comments...